menu

Alzheimer’s Drugs Market

Schedule Call

Alzheimer’s Drugs Market

Alzheimer's Drugs Market by Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists), End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Global Outlook & Forecast 2024-2032

GR - 299032 Category: Pharmaceuticals

Number of pages: 120  |  Report Format: PDF  |  Published date: March 01, 2021

Historical Years – 2022  |  Base Year – 2023  |  Forecasted Years – 2024-2032


Alzheimer’s Drugs Market Scope

Report Attribute

Details

Market Size Value in 2023

US$ 5.1 billion

Revenue Forecast in 2032

US$ 8.2 billion

CAGR

5.5%

Base Year for Estimation

2023

Forecast Period

2024 to 2032

Historical Year

2022

Segments Covered

Drug Class, End User, and Region

Regional Scope

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global Alzheimer's drugs market was valued at US$ 5.1 billion in 2023 and is expected to register a revenue CAGR of 5.5% to reach US$ 8.2 billion by 2032

Introduction
The " Global Alzheimer's drugs Market Report 2022-2032" offers an extensive analysis of the global Alzheimer's drugs market, providing valuable insights into the latest trends, market drivers, challenges, and future outlook. This report is essential for stakeholders seeking to understand the evolving landscape and capitalize on emerging opportunities in the Alzheimer’s sector.

Geographical Scope and Study Timeline

  • Regions Covered: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
  • Study Period: 2022-2032
  • Market Segmentation: By Drug Class, By End User and Region

Alzheimer’s Market Overview
This section provides a detailed overview of Alzheimer’s, including the current state of research, technological advancements, and key developments. The report covers disease mechanisms, patient demographics, and current treatment protocols, setting the stage for a deeper understanding of the market.

Epidemiology and Patient Demographics
Explore the epidemiological trends of Alzheimer’s across key regions, with a focus on prevalence, incidence, and patient population dynamics. This section provides a foundation for understanding the potential market size and growth opportunities.

Treatment Landscape and Pipeline Review
The report includes a comprehensive review of the treatment landscape, covering both established therapies and those in the pipeline. Each therapy is evaluated based on its clinical efficacy, safety profile, and market potential, offering insights into the future of Alzheimer’s treatment.

Market Dynamics and Trends

  • Key Market Drivers: Analysis of the factors driving market growth, including innovation in treatment modalities, rising disease awareness, and favorable regulatory environments.
  • Market Challenges: Discussion of barriers to market growth, such as high development costs, regulatory hurdles, and competition from alternative therapies.
  • Emerging Trends: Identification of emerging trends, including the adoption of personalized medicine, advancements in biotechnology, and shifts in healthcare policy.

Market Forecast and Opportunity Analysis

  • Market Projections: Detailed market projections for the Alzheimer's drugs market from 2022 to 2032, segmented by region, drug class and end user.
  • Opportunity Analysis: Identification of key opportunities for market entry, expansion, and innovation, with a focus on unmet needs and market gaps.

Key Opinion Leader (KOL) Insights: Primary research insights from KOLs and Subject Matter Experts (SMEs) in the Alzheimer’s domain, offering perspectives on treatment patterns, emerging trends, and market opportunities.

Strategic Insights and Recommendations
The report concludes with actionable insights and recommendations for stakeholders looking to navigate the Alzheimer's drugs market successfully. Strategies for market entry, product development, and competitive positioning are discussed, helping clients to achieve long-term success.

Alzheimer's Competitive Landscape

This section profiles the leading companies in the Alzheimer's drugs market, highlighting their product portfolios, R&D activities, and strategic initiatives. The report also provides an analysis of market share by key players, offering a clear picture of the competitive environment. Some of the prominent market players in the global Alzheimer's drugs market include,

Frequently Asked Questions About This Report

Alzheimer's disease is a brain ailment that gradually impairs memory, cognitive skills, and the capacity to do even the most basic tasks. Symptoms of Alzheimer's disease usually show later in life in the majority of people. Alzheimer's disease is the seventh-largest cause of mortality in the United States and the primary cause of dementia in older persons.

North America region is dominating the global Alzheimer's drugs market.

The estimated market size of the Alzheimer's drugs market in 2032 will be 8.2 billion.

The revenue CAGR of the Alzheimer's drugs market during the forecast period will be 5.5%.

Some prominent market players in the global Alzheimer's drugs include Eisai Co., Ltd., F. Hoffmann La Roche Ltd., and Novartis AG.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2022
      2. Base Year – 2023
      3. Forecast Years – 2024 to 2032
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2023)
    3. Regulatory Landscape
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL ALZHEIMER’S DRUGS MARKET - ANALYSIS & FORECAST, BY DRUG CLASS
    1. Cholinesterase Inhibitors
    2. NMDA Receptor Antagonists
    3. Other (Combination Drugs, Monoclonal Antibody, Etc.)
  6. GLOBAL ALZHEIMER’S DRUGS MARKET - ANALYSIS & FORECAST, BY END USER
    1. Hospitals Pharmacy
    2. Retail Pharmacy
    3. Online Pharmacy
  7. GLOBAL ALZHEIMER’S DRUGS MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Alzheimer’s Drugs Market
      1. North America Alzheimer’s Drugs Market, By Drug Class
      2. North America Alzheimer’s Drugs Market, by End User
      3. North America Alzheimer’s Drugs Market, by Country
        1. U.S.
          1. U.S. Alzheimer’s Drugs Market, By Drug Class
          2. U.S. Alzheimer’s Drugs Market, by End User
        2. Canada
          1. Canada Alzheimer’s Drugs Market, By Drug Class
          2. Canada Alzheimer’s Drugs Market, by End User
    2. Europe Alzheimer’s Drugs Market
      1. Europe Alzheimer’s Drugs Market, By Drug Class
      2. Europe Alzheimer’s Drugs Market, by End User
      3. Europe Alzheimer’s Drugs Market, by Country/Region
        1. Germany
          1. Germany Alzheimer’s Drugs Market, By Drug Class
          2. Germany Alzheimer’s Drugs Market, by End User
        2. U.K.
          1. U.K. Alzheimer’s Drugs Market, By Drug Class
          2. U.K. Alzheimer’s Drugs Market, by End User
        3. France
          1. France Alzheimer’s Drugs Market, By Drug Class
          2. France Alzheimer’s Drugs Market, by End User
        4. Spain
          1. Spain Alzheimer’s Drugs Market, By Drug Class
          2. Spain Alzheimer’s Drugs Market, by End User
        5. Italy
          1. Italy Alzheimer’s Drugs Market, By Drug Class
          2. Italy Alzheimer’s Drugs Market, by End User 
        6. Rest of Europe 
          1. Rest of Europe Alzheimer’s Drugs Market, By Drug Class
          2. Rest of Europe Alzheimer’s Drugs Market, by End User
    3. Asia Pacific Alzheimer’s Drugs Market
      1. Asia Pacific Alzheimer’s Drugs Market, By Drug Class
      2. Asia Pacific Alzheimer’s Drugs Market, by End User
      3. Asia Pacific Alzheimer’s Drugs Market, by Country/Region
        1. China
          1. China Alzheimer’s Drugs Market, By Drug Class
          2. China Alzheimer’s Drugs Market, by End User
        2. Japan
          1. Japan Alzheimer’s Drugs Market, By Drug Class
          2. Japan Alzheimer’s Drugs Market, by End User
        3. India
          1. India Alzheimer’s Drugs Market, By Drug Class
          2. India Alzheimer’s Drugs Market, by End User
        4. South Korea
          1. South Korea Alzheimer’s Drugs Market, By Drug Class
          2. South Korea Alzheimer’s Drugs Market, by End User
        5. Australia
          1. Australia Alzheimer’s Drugs Market, By Drug Class
          2. Australia Alzheimer’s Drugs Market, by End User
        6. Rest of Asia Pacific
          1. Rest of Asia Pacific Alzheimer’s Drugs Market, By Drug Class
          2. Rest of Asia Pacific Alzheimer’s Drugs Market, by End User
    4. Latin America Alzheimer’s Drugs Market
      1. Latin America Alzheimer’s Drugs Market, By Drug Class
      2. Latin America Alzheimer’s Drugs Market, by End User
      3. Latin America Alzheimer’s Drugs Market, by Country
        1. Brazil 
          1. Brazil Alzheimer’s Drugs Market, By Drug Class
          2. Brazil Alzheimer’s Drugs Market, by End User
        2. Mexico 
          1. Mexico Alzheimer’s Drugs Market, By Drug Class
          2. Mexico Alzheimer’s Drugs Market, by End User
        3. Argentina 
          1. Argentina Alzheimer’s Drugs Market, By Drug Class
          2. Argentina Alzheimer’s Drugs Market, by End User
        4. Rest of Latin America 
          1. Rest of Latin America Alzheimer’s Drugs Market, By Drug Class
          2. Rest of Latin America Alzheimer’s Drugs Market, by End User 
    5. Middle East & Africa Alzheimer’s Drugs Market
      1. Middle East & Africa Alzheimer’s Drugs Market, By Drug Class
      2. Middle East & Africa Alzheimer’s Drugs Market, by End User
      3. Middle East & Africa Alzheimer’s Drugs Market, by Country
        1. GCC Countries
          1. GCC Countries Alzheimer’s Drugs Market, By Drug Class
          2. GCC Countries Alzheimer’s Drugs Market, by End User
          3. South Africa
            1. South Africa Alzheimer’s Drugs Market, By Drug Class
            2. South Africa Alzheimer’s Drugs Market, by End User
          4. Rest of Middle East & Africa
            1. Rest of Middle East & Africa Alzheimer’s Drugs Market, By Drug Class
            2. Rest of Middle East & Africa Alzheimer’s Drugs Market, by End User
  8. COMPANY PROFILE
    1. Eisai Co., Ltd.
      1. Business Snapshot 
      2. Products Offered 
      3. Financial Details 
      4. Strategic Developments
    2. F. Hoffmann La Roche Ltd.
    3. Novartis AG
    4. Adamas Pharmaceuticals, Inc.
    5. H. Lundbeck A/S
    6. AbbVie Inc. (Allergan Plc.)
    7. Biogen
    8. Daiichi Sankyo Company, Limited
    9. Johnson & Johnson Services, Inc.
    10. AC Immune
    11. TauRx Pharmaceuticals Ltd.

*Insights on financial performance are subject to the availability of information in the public domain

List of Tables

  1. Global Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  2. Global Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  3. Global Alzheimer’s Drugs Market, by Region, 2022-2032 (US$ Million)
  4. North America Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  5. North America Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  6. North America Alzheimer’s Drugs Market, by Country, 2022-2032 (US$ Million)
  7. U.S. Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  8. U.S. Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  9. Canada Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  10. Canada Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  11. Europe Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  12. Europe Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  13. Europe Alzheimer’s Drugs Market, by Country/Region, 2022-2032 (US$ Million)
  14. Germany Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  15. Germany Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  16. U.K. Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  17. U.K. Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  18. France Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  19. France Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  20. Italy Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  21. Italy Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  22. Spain Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  23. Spain Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  24. Rest of Europe Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  25. Rest of Europe Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  26. Asia Pacific Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  27. Asia Pacific Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  28. Asia Pacific Alzheimer’s Drugs Market, by Country/Region, 2022-2032 (US$ Million)
  29. China Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  30. China Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  31. Japan Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  32. Japan Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  33. India Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  34. India Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  35. South Korea Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  36. South Korea Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  37. Australia Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  38. Australia Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  39. Rest of Asia Pacific Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  40. Rest of Asia Pacific Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  41. Latin America Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  42. Latin America Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  43. Latin America Alzheimer’s Drugs Market, by Country, 2022-2032 (US$ Million)
  44. Brazil Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  45. Brazil Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  46. Mexico Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  47. Mexico Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  48. Argentina Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  49. Argentina Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  50. Rest of Latin America Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  51. Rest of Latin America Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  52. Middle East & Africa Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  53. Middle East & Africa Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  54. Middle East and Africa Alzheimer’s Drugs Market, by Country/Region, 2022-2032 (US$ Million)
  55. GCC Countries Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  56. GCC Countries Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  57. South Africa Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  58. South Africa Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)
  59. Rest of Middle East and Africa Alzheimer’s Drugs Market, By Drug Class, 2022-2032 (US$ Million)
  60. Rest of Middle East and Africa Alzheimer’s Drugs Market, by End User, 2022-2032 (US$ Million)

List of Figures

  1. Alzheimer’s Drugs Market Ecosystem  
  2. Snapshot of Global Alzheimer’s Drugs Market, 2022-2032 
  3. Snapshot of Global Alzheimer’s Drugs Market, By Region, 2022-2032 
  4. Global Alzheimer’s Drugs Market: COVID-19 Pandemic Impact Assessment 
  5. Global Alzheimer’s Drugs Market: Key Players & Competitive Positioning (2023) 
  6. Alzheimer’s Drugs: Market Dynamics 
  7. Global Alzheimer’s Drugs Market for Cholinesterase Inhibitors, 2022-2032 (US$ Million)
  8. Global Alzheimer’s Drugs Market for NMDA Receptor Antagonists, 2022-2032 (US$ Million)
  9. Global Alzheimer’s Drugs Market for Others, 2022-2032 (US$ Million)
  10. Global Alzheimer’s Drugs Market for Hospitals Pharmacy, 2022-2032 (US$ Million)
  11. Global Alzheimer’s Drugs Market for Retail Pharmacy, 2022-2032 (US$ Million)
  12. Global Alzheimer’s Drugs Market for Online Pharmacy, 2022-2032 (US$ Million)
  13. U.S. Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  14. Canada Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  15. Germany Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  16. U.K. Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  17. France Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  18. Italy Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  19. Spain Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  20. Rest of Europe Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  21. China Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  22. Japan Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  23. India Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  24. South Korea Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  25. Australia Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  26. Rest of Asia Pacific Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  27. Brazil Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  28. Mexico Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  29. Argentina Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  30. Rest of Latin America Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  31. GCC Countries Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  32. South Africa Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  33. Rest of Middle East & Africa Alzheimer’s Drugs Market, 2022-2032 (US$ Million)
  34. Eisai Co., Ltd. Revenue from 2021 Onwards (US$ Million)
  35. F. Hoffmann La Roche Ltd. Revenue from 2021 Onwards (US$ Million)
  36. Novartis AG Revenue from 2021 Onwards (US$ Million)
  37. Adamas Pharmaceuticals, Inc. Revenue from 2021 Onwards (US$ Million)
  38. H. Lundbeck A/S Revenue from 2021 Onwards (US$ Million)
  39. AbbVie Inc. (Allergan Plc.) Revenue from 2021 Onwards (US$ Million)
  40. Biogen Revenue from 2021 Onwards (US$ Million)
  41. Daiichi Sankyo Company, Limited Revenue from 2021 Onwards (US$ Million)
  42. Johnson & Johnson Services, Inc. Revenue from 2021 Onwards (US$ Million)
  43. AC Immune Revenue from 2021 Onwards (US$ Million)
  44. TauRx Pharmaceuticals Ltd. Revenue from 2021 Onwards (US$ Million)

Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.
  • What are the significant driving and restraining factors for the Alzheimer’s Drugs Market?
  • Who are the leading companies in the market?
  • Where can you find the updates on recent developments by market players?
  • When is the right time to get discounts on complete market reports?
  • Why to invest in the Alzheimer’s Drugs Market?
  • How to improve your organizational performance?
  • How to shift customers towards your brand?

Recommended Reports